Preclinical evaluation of brimonidine

Survey of Ophthalmology

Volumn 41, Issue SUPPL. 1, 1996, Pages

  Burke, J ^a   Schwartz, M ^a  

^a ALLERGAN INC   (United States)

Author keywords

AGN190342; alpha2 adrenoceptor; apraclonidine; brimonidine; clonidine; glaucoma; intraocular pressure; lopidine; neuroprotection; p aminoclonidine; UK 14,304

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; APRACLONIDINE; BRIMONIDINE; CLONIDINE; LOPIDINE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL MODEL; BRAIN ISCHEMIA; BRAIN PROTECTION; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG MECHANISM; EXPERIMENTAL MODEL; GLAUCOMA; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE ABNORMALITY; NONHUMAN; OPTIC NERVE; PRIORITY JOURNAL; RABBIT; RETINA BLOOD VESSEL; REVIEW; TOPICAL DRUG ADMINISTRATION;

EID: 0029752042     PISSN: 00396257     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0039-6257(96)82027-3     Document Type: Review

References (65)

1. DA Abrams AL Robin IP Pollack The safety and efficacy of topical 1% ALO 2145 ( p -aminoclonidine hydrochloride) in normal volunteers Arch Ophthalmol 105 1987 1205 1207
2. A Acheampong M Shackleton D Tang-Liu Comparative ocular pharmacokinetics of brimonidine after a single dose application to the eyes of albino and pigmented rabbits Drug Metabolism and Disposition 23 1995 708 712
3. O Angelov A Wiese M Ismail Reproductive and development safety studies with brimonidine (Alphagan) [abstract] Invest Ophthalmol Vis Sci 37 1996 S1101
4. O Angelov A Wiese D Tang-Liu Preclinical safety profile of brimonidine Eur J Ophthalmol 6 1996 21 25
5. JA Angus TM Cocks CE Wright Endothelium-dependent responses in large arteries and in the microcirculation PM Vanhoutte Relaxing and Contracting Factors 1988 Humana Press Clifton 361 387
6. M Araie M Takase Y Sakai Beta-adrenergic blockers: ocular penetration and binding to the uveal pigment Jpn J Ophthalmol 26 1982 248 263
7. CS Bockman WB Jeffries PW Abel Binding and functional characterizations of alpha-2 adrenergic receptor subtypes on pig vascular endothelium J Pharmacol Exp Ther 267 1993 1126 1133
8. J Burke C Crosson DE Potter Can UK-14304-18 lower IOP in rabbits by a peripheral mechanism? Curr Eye Res 8 1989 547 552
9. J Burke A Kharlamb T Shan Adrenergic and imidazoline receptor-mediated responses to UK- 14,304-18 (brimonidine) in rabbits and monkeys: A species difference D Reis P Bousquet A Parini The Imidazoline Receptor: Pharmacology, Functions, Ligands, and Relevance to Biology and Medicine 1995 The New York Academy of Sciences New York 78 95
10. J Burke C Manlapaz E Padillo Alpha-adrenoceptor and ocular pharmacology of brimonidine, p -aminoclonidine and clonidine (abstract) XX Pan-American Congress on Ophthalmology 1995 110 Quito, Equador
11. 2-adrenoceptor agonists, brimonidine, p -aminoclonidine and clonidine (abstract) International Symposium on Experimental and Clinical Ocular Pharmacology and Pharmaceutics 1995 29 Geneva, Switzerland
12. J Burke E Padillo T Dang Differential desensitization of alpha adrenoceptors modulating intraocular pressure (IOP) changes to brimonidine in the rabbit (abstract) Invest Ophthalmol Vis Sci 36 1995 S717
13. J Burke E Padillo T Shan AGN 190342 (UK-14304-18) stimulates an imidazoline receptor to lower intraocular pressure IOP in conscious monkeys (abstract) Invest Ophthahnol Vis Sci 32 1991 867
14. JA Burke DE Potter Ocular effects of a relatively selective alpha 2 agonist (UK-14, 304-318) in cats, rabbits and monkeys Curr Eye Res 5 1986 665 676
15. 2-adrenergic Receptors: Structure, Function and Therapeutic Implications 1996 Harwood Academic Publishers Reading, UK 179 187
16. P Butler M Mannschreck S Lin Clinical experience with the long-term use of 1% apraclonidine: Incidence of allergic reactions Arch Ophthalmol 113 1995 293 296
17. D Cambridge UK-14,304, a potent and selective alpha-2 agonist for the characterization of alpha-adrenoceptor sub-type Eur J Pharmacol 72 1981 413 415
18. M Chandler L DeSantis Studies of apraclonidine as a potential antiglaucoma agent (abstract) Invest Vis Sci 26 1985 227
19. D-S Chien JJ Homsy C Gluchowski DDS Tang-Liu Corneal and conjunctival/scleral penetration of p -aminoclonidine, AGN 190342, and clonidine in rabbit eyes Curr Eye Res 9 1990 1051 1059
20. D-S Chien J Richman H Zolezio Drug distribution of brimonidine in albino and pigmented rabbit eyes (abstract) Pharm Res 9 1992 S336
21. A Coleman AL Robin I Pollack Apraclonidine hydrochloride TJ Zimmerman KS Kooner Ophthahnol Clin N Am 1989 WB Saunders Company Philadelphia 97 108
22. JE Faber GA Meininger Selective interaction of alpha-adrenoceptors with myogenic regulation of microvascular smooth muscle Am J Physiol 259 1990 H1126 H1133
23. WH Fahrenbach DR Bacon EM Van Buskirk Microvascular responses to chronic glaucoma drug therapy (abstract) Invest Ophthalmol Vis Sci 32 1991 944
24. WH Fahrenbach DR Bacon EM Van Buskirk Vasoactive drug effects on the uveal vasculature of the rabbit: a corrosion casting study (abstract) Invest Ophthalmol Vis Sci 30 1989 100
25. BT Gabelt JC Robinson WC Hubbard Apraclonidine and brimonidine effects on anterior ocular and cardiovascular physiology on normal and sympathectomized monkeys Exp eye Res 59 1994 633 644
26. R Harrison CS Kaufmann Clonidine: Effects of a topically administered solution on intraocular pressure and blood pressure in open-angle glaucoma Arch Ophthalmol 95 1977 1368 1373
27. K Heilmann Studies on the effect of Catapress on intraocular pressure Klin Montasbl Augenheilkd 161 1972 1368 1373
28. E Hodapp AE Kolker MA Kass The effect of topical clonidine on intraocnlar pressure Arch Ophthalmol 99 1981 1208 1211
29. 2-adrenoceptor stimulation on intraocular pressure in the conscious rabbit Arch Pharmacol 316 1981 294 298
30. WL Joyner JP Gilmore Tissues grafted into the hamster cheek pouch CH Baker WL Nastok Physical Techniques in Biology and Medicine Volume X 1986 Academic Press New York 3 17
31. 1 Imidazoline receptor subtype mediates ocular hypotensive and cardiovascular effects of brimonidine (UK 14,304) in cynomolgus monkeys (abstract) Invest Ophthalmol Vis Sci 35 1994 2048
32. A Kharlamb T Shan E Runde The cynomolgus monkey has a CNS imidazoline receptor which mediated IOP and cardiovascular responses to UK-14,304 (AGN 190342) (abstract) Invest Ophthalmol Vis Sci 33 1992 1115
33. F Konno I Takayanagi Characterization of postsynaptic alpha-1 adrenoceptors in the rabbit dilator smooth muscle Arch Pharmacol 333 1986 271 276
34. GK Krieglstein ME Langham W Leydhecker The peripheral and central neural actions of clonidine in normal and glaucomatous eyes Invest Ophthalmol Vis Sci 17 1978 149 158
35. 2-adrenoceptor antagonists when compared on isolated vasa deferentia of rat and rabbit Naunyn-Schmiedeberg's Arch Pharmacol 329 1985 278 281
36. P-Y Lee JB Serle SM Podos Time course of the effect of UK 14304-18 (brimonidine tartrate) on rabbit uveoscleral outflow (abstract) Invest Ophthalmol Vis Sci 33 1992 1118
37. AJ Lish CB Camras SM Podos Effect of apraclonidine on intraocular pressure in glaucoma patients receiving maximally tolerated medications J Glaucoma 1 1992 19 22
38. DR Lynch TM Dawson Secondary mechanisms in neuronal trauma Curr Opin Neurol 7 1994 175 186
39. C Maier GK Steinberg GH Sun Neuroprotection by the alpha-2 adrenoreceptor agonist dexmedetomidine in a focal model of cerebral ischemia Anesthesiology 79 1993 306 312
40. KM McGillivray-Anderson JE Faber Effect of reduced blood flow on alpha 1- and alpha 2-adrenoceptor constriction of rat skeletal muscle microvessels Circ Res 69 1991 165 173
41. 2-adrenoceptor agonists. Twist and agent polarity as design elements Bioorg Med Chem Lett 4 1994 459 462
42. 2-adrenoceptor activity Bioorg Med Chem Lett 5 1995 1745 1750
43. 2-agonists (abstract) Invest Ophthalmol Vis Sci 37 1996 S832
44. DL Murray IH Leopold Alpha adrenergic receptors in rabbit eyes J Ocular Pharmacol 1 1985 3 18
45. AJ Nichols Functions mediated by a-adrenoceptors RR Ruffolo Alpha Adrenoceptors: Molecular Biology, Biochemistry and Pharmacology 1991 Karger New York 115 179
46. S Podos C Camras J Serle Pharmacological alteration of aqueous humor dynamics in normotensive and glaucomatous monkeys eyes GK Krieglstein Glaucoma Update III 1987 Springer-Verlag Berlin 225 235
47. DJ Reis S Regunathan MP Meeley Imidazole receptors and clonidine-displacing substance in relationship to control of blood pressure, neuroprotection, and adrenomedullary secretion Am J Hypertens 5 1992 51S 57S
48. AL Robin Questions concerning the role of apraclonidine in the management of glaucoma Arch Ophthalmol 113 1995 712 714
49. AL Robin Short-term effects of unilateral 1% apraclonidine therapy Arch Ophthahnol 106 1988 912 915
50. JS Schuman Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension Surv Ophthalmol 41 Suppl 1 1996 S27 S37
51. CL Serdahl J Galustian RA Lewis The effects of apraclonidine on conjunctival oxygen tension Arch Ophthalmol 107 1989 1777 1779
52. JB Serle A comparison of the safety and efficacy of twice daily brimonidine 0.2% versus betaxolol 0.25% in subjects with elevated intraocular pressure Surv Ophthalmol 41 Suppl 1 1996 S39 S46
53. 2-adrenergic agonists on uveoscleral outflow in rabbits (abstract) Invest Ophthalmol Vis Sci 32 1991 867
54. 2-adrenergic agonists B-HT 920 and UK14,304-18: Effects on aqueous humor in monkeys Arch Ophthalmol 109 1991 1158 1162
55. MB Shields Adrenergic stimulators MB Shields C-L Brown Textbook of Glaucoma 1992 Williams and Wilkins Baltimore 462 479
56. 2-adrenoceptor agonists on microvessel caliber in human retinal tissue K Messmerk W Kubler Sixth World Congress for Microcirculation 1996 511 514
57. D Tang-Liu A Acheampong D-S Chien The effect of melanin binding on brimonidine disposition in rabbit eyes (abstract) Invest Ophthalmol Vis Sci 33 1992 1015
58. CB Toris ML Gleason CB Camras ME Yablonski Effects of brimonidine on aqueous humor dynamics in human eyes Arch Ophthalmol 113 1995 1514 1517
59. GW van Alphen R Kern SL Robinette Adrenergic receptors of the intraocular muscles: comparison of cat, rabbit and monkey Arch Ophthalmol 74 1965 253 259
60. EM Van Buskirk DR Bacon WH Fahrenbach Ciliary vasoconstriction after topical adrenergic drugs Am J Ophthalmol 109 1990 511 517
61. T Walters Development and use of brimonidine in treating acute and chronic elevations of intraocular pressure: A review of safety, efficacy, dose response, and dosing studies Surv Ophthalmol 41 Suppl 1 1996 S19 S26
62. 2-Adrenergic agonists induce basic fibroblast growth factor expression in photoreceptors in vivo and ameliorate light damage J Neurosci 16 1996 5986 5992
63. 2-adrenergic agonists xylazine or clonidine induces bFGF expression in photoreceptors (abstract) Invest Ophthalmol Vis Sci 37 1996 S436
64. 2-adrenoceptor agonists, brimonidine, apraclonidine and clonidine (abstract) Eur J Ophthalmol 5 2A suppl 1995 156
65. 2-adrenoceptor agonists AGN 191103 and brimonidine (abstract) Invest Ophthahnol Vis Sci 3 suppl 1996 S114